Superior vena cava syndrome natural history, complications and prognosis: Difference between revisions
Hardik Patel (talk | contribs) No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Superior vena cava syndrome}} | {{Superior vena cava syndrome}} | ||
{{CMG}} | {{CMG}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
==Complications== | ==Complications== | ||
*The [[throat]] could become blocked, which can block the airways. | |||
* The throat could become blocked, which can block the airways. | *Increased pressure may develop in the [[brain]], leading to changed levels of [[consciousness]], [[nausea]], [[vomiting]], or vision changes. | ||
* Increased pressure may develop in the brain, leading to changed levels of [[consciousness]], [[nausea]], [[vomiting]], or vision changes. | |||
==Prognosis== | ==Prognosis== | ||
*The outcome varies depending on the cause and the amount of blockage. | |||
* The outcome varies depending on the cause and the amount of blockage. | *SVCS caused by a [[tumor]] is a sign that the tumor has spread, and it indicates a poorer long-term outlook. | ||
* SVCS caused by a tumor is a sign that the tumor has spread, and it indicates a poorer long-term outlook. | *[[Cancer]] patients diagnosed with SVCS do not die of the syndrome itself but rather from the extent of their underlying disease. | ||
* Cancer patients diagnosed with SVCS do not die of the syndrome itself but rather from the extent of their underlying disease. | *SVCS is usually a sign of locally advanced [[bronchogenic carcinoma]]. Survival depends on the status of the patient’s disease. When small cell [[bronchogenic carcinoma]] is treated with [[chemotherapy]], the 24-month survival rate is 9% in patients without SVCS and 3% in those with the syndrome. When the [[malignancy]] is treated with radiation therapy, 46% of patients who have non-small cell [[lung cancer]] experience relief of symptoms compared with 62% of patients who have small cell [[bronchogenic carcinoma]]. The 2-year survival rate of 5% is almost the same for both groups. | ||
* SVCS is usually a sign of locally advanced bronchogenic carcinoma. Survival depends on the status of the patient’s disease. When small cell bronchogenic carcinoma is treated with | *Most [[non-Hodgkin lymphoma]] patients with SVCS respond to appropriate [[chemotherapy]] or to combined modality regimens. | ||
* Most non-Hodgkin lymphoma patients with SVCS respond to appropriate chemotherapy or to combined modality regimens. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | |||
[[Category:Oncology]] | |||
[[Category:Otolaryngology]] | |||
[[Category:Hematology]] | |||
[[Category:Cardiology]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Intensive care medicine]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 15:50, 22 January 2013
Superior Vena Cava Syndrome Microchapters |
Differentiating Superior Vena Cava Syndrome from Other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Superior vena cava syndrome natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Superior vena cava syndrome natural history, complications and prognosis |
FDA on Superior vena cava syndrome natural history, complications and prognosis |
CDC on Superior vena cava syndrome natural history, complications and prognosis |
Superior vena cava syndrome natural history, complications and prognosis in the news |
Blogs on Superior vena cava syndrome natural history, complications and prognosis |
Directions to Hospitals Treating Superior vena cava syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Complications
- The throat could become blocked, which can block the airways.
- Increased pressure may develop in the brain, leading to changed levels of consciousness, nausea, vomiting, or vision changes.
Prognosis
- The outcome varies depending on the cause and the amount of blockage.
- SVCS caused by a tumor is a sign that the tumor has spread, and it indicates a poorer long-term outlook.
- Cancer patients diagnosed with SVCS do not die of the syndrome itself but rather from the extent of their underlying disease.
- SVCS is usually a sign of locally advanced bronchogenic carcinoma. Survival depends on the status of the patient’s disease. When small cell bronchogenic carcinoma is treated with chemotherapy, the 24-month survival rate is 9% in patients without SVCS and 3% in those with the syndrome. When the malignancy is treated with radiation therapy, 46% of patients who have non-small cell lung cancer experience relief of symptoms compared with 62% of patients who have small cell bronchogenic carcinoma. The 2-year survival rate of 5% is almost the same for both groups.
- Most non-Hodgkin lymphoma patients with SVCS respond to appropriate chemotherapy or to combined modality regimens.